Lucid Diagnostics
(NASDAQ:LUCD)
$0.9051
0.0151[1.69%]
Last update: 2:30PM Get Real Time Here
Q1 2024 Earnings were released on Mon May 13th, before the market open
The most recent conference call was at 8:30 AM, 4 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Lucid Diagnostics Stock (NASDAQ:LUCD), Quotes and News Summary

Lucid Diagnostics Stock (NASDAQ: LUCD) stock price, news, charts, stock research, profile.

Open$0.890
Close-
Volume / Avg.78.666K / 226.170K
Day Range0.880 - 0.934
52 Wk Range0.630 - 1.850
Market Cap$47.166M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
50
Short Interest
2.43%
Days to Cover2.22

Recent News

Why PAVmed Shares Are Falling Today
PAVmed Inc. (NASDAQ: PAVM) shares are trading lower after the company announced a workforce reduction of roughly 20% alongside other cost-cutting measures.
Sean Torres
PAVmed, Lucid Diagnostics Pause Some Development Programs, Announce Layoffs
Vandana Singh
10 Biggest Price Target Changes For Tuesday
BTIG cut the price target on NeoGenomics, Inc. (NASDAQ: NEO) from $35 to $28. NeoGenomics shares fell 29.2% to $12.60 in pre-market trading.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
Mar
1
Apr
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
LUCD
POCI

FAQ

Q

How do I buy Lucid Diagnostics (LUCD) stock?

A

You can purchase shares of Lucid Diagnostics (NASDAQ: LUCD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lucid Diagnostics's (LUCD) competitors?

A

Other companies in Lucid Diagnostics’s space includes: Precision Optics Corp (NASDAQ:POCI), LENSAR (NASDAQ:LNSR), Autonomix Medical (NASDAQ:AMIX), Modular Medical (NASDAQ:MODD) and NeuroOne Medical Tech (NASDAQ:NMTC).

Q

What is the target price for Lucid Diagnostics (LUCD) stock?

A

The latest price target for Lucid Diagnostics (NASDAQ: LUCD) was reported by Cantor Fitzgerald on Wednesday, May 15, 2024. The analyst firm set a price target for 3.00 expecting LUCD to rise to within 12 months (a possible 229.67% upside). 10 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lucid Diagnostics (LUCD)?

A

The stock price for Lucid Diagnostics (NASDAQ: LUCD) is $0.91 last updated Today at May 17, 2024 at 8:27 AM EDT.

Q

Does Lucid Diagnostics (LUCD) pay a dividend?

A

There are no upcoming dividends for Lucid Diagnostics.

Q

When is Lucid Diagnostics (NASDAQ:LUCD) reporting earnings?

A

Lucid Diagnostics’s Q2 earnings are confirmed for Monday, August 12, 2024.

Q

Is Lucid Diagnostics (LUCD) going to split?

A

There is no upcoming split for Lucid Diagnostics.

Q

What sector and industry does Lucid Diagnostics (LUCD) operate in?

A

Lucid Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

People Also Watch